Contingency Management to Promote Smoking Cessation

Launched by UNIVERSITY OF KANSAS MEDICAL CENTER · Jun 11, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to help people quit smoking using a technique called contingency management (CM), which involves sending supportive texts to encourage participation in smoking cessation programs. The study will involve 20 participants who smoke and will receive a referral to a quitline, a prescription for a medication called varenicline to help with cravings, and 12 weeks of text messages designed to keep them engaged in their quitting journey. Researchers will track how often participants use the quitline and their medication over the next few months to see how well this approach works.

To be eligible for this trial, participants must have smoked at least one cigarette a day in the last month, be at least 18 years old, live in Kansas, and be able to read and understand English. They also need to have a mobile phone that can receive text messages and have insurance that covers the medication. Participants will not be able to join if they have certain health conditions, if they are pregnant or breastfeeding, or if they recently received other smoking cessation treatments. This study aims to find out if this text-based support can help more people successfully quit smoking.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Smoked in the past 30 days
• • Smoke at least 1 cigarette per day when they smoke
• • ≥ 18 years old
• • Kansas resident
• • Speak/read English
• • Access to a mobile phone
• • Mobile phone receives text messages
• • No varenicline contraindications (no acute renal impairment)
• • Insurance coverage for varenicline
• • Have no significant co-morbidity (i.e., life-threatening illness, communication barriers or altered mental status)
• • Cognitively able to participate
• • Physically able to participate
• • Not pregnant/breastfeeding
• Exclusion Criteria:
• • Medically ineligible for varenicline
• • Patient on smoking cessation medication within 2 weeks of admission date
• • Patient already talked to quitline in the past 2 weeks.
• • Patients participating in other quit smoking program or research study